FDA panel recommends easing some peptide restrictions despite disapproval from scientists
A Food and Drug Administration advisory committee narrowly voted in favor of loosening restrictions on peptides over strong objections from agency career scientists. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. Throughout the daylong meeting, FDA scientists detailed a lack of evidence supporting the use of the peptides…